Whether you are a healthcare professional, researcher, or student in the life sciences, this course will

He has led teams that have filed more than 10 Investigational New Drug Applications (IND), as well as In 2007 he formed IndiPharm which was a full-service Contract Research Organization whose operational headquarters were in Mumbai, India. He received his undergraduate Bachelor of Science Degree in Pharmacy from The Philadelphia College of He went on to study medicine at the Royal College of Surgeons in Ireland before receiving his Medical

GPCR podcast is here! 🎧Hear Dr. Nicholas Holliday and how he has combined his university role with his leadership of Excellerate Bioscience

After all, he also complained that the perfect is the enemy of the good. If only Voltaire were here today to see how drug discovery is being accelerated by new technologies. He might reverse himself and declare that the perfect can in fact be the friend of the good.

He did B.Sc. in biology at McGill University and received his Ph.D. under the mentorship of Dr. He did his postdoctoral training with Dr. Marc G. He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Most recently, in 2021, he was elected as a Fellow of the Canadian Academy of Health Science (FCAHS). He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for

He also directs a collaborative neuroscience R&D program with Servier (France) and is the co-founder Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology company (2009-2012), where he was responsible all of the company’s discovery biology. He is an acknowledged expert in drug discovery, particularly in the field of psychiatry, where he has He is also a corresponding member of NC-IUPHAR.

Prior to Crinetics, he was senior director and head of endocrinology and metabolism at Neurocrine Biosciences At Neurocrine, he initiated and led the effort to discover and develop orally active, nonpeptide GnRH Prior to Neurocrine, from 1995 to 1998, he co-founded ScienceMedia Inc. to develop eLearning solutions In addition, he is a member of the board of directors of the San Diego Entrepreneurs Exchange, a nonprofit organization that provides resources for early-stage start-ups, which he co-founded in [2009.]